ZNF503 and glioma: In this study, we used datasets from TCGA and CGGA to study the role of ZNF503-AS2 in glioma and its relationship with prognosis, molecular subtype, immune microenvironment, inflammatory response, and immune checkpoint blockade (ICB) treatment.